|
1
|
Stoll BA: Upper abdominal obesity, insulin
resistance and breast cancer risk. Int J Obes Relat Metab Disord.
26:747–753. 2002.PubMed/NCBI
|
|
2
|
Macciò A, Madeddu C and Mantovani G:
Adipose tissue as target organ in the treatment of
hormone-dependent breast cancer: New therapeutic perspectives. Obes
Rev. 10:660–670. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo
FC, Fu OY, Chen HY, Hou MF and Yuan SS: Serum adiponectin and
leptin levels in Taiwanese breast cancer patients. Cancer Lett.
237:109–114. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH,
Yu CP, Yu JC and Sun CA: Circulating levels of leptin, adiposity
and breast cancer risk. Br J Cancer. 100:578–582. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dalamaga M, Archondakis S, Sotiropoulos G,
Karmaniolas K, Pelekanos N, Papadavid E and Lekka A: Could serum
visfatin be a potential biomarker for postmenopausal breast cancer?
Maturitas. 71:301–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kang JH, Yu BY and Youn DS: Relationship
of serum adiponectin and resistin levels with breast cancer risk. J
Korean Med Sci. 22:117–121. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dalamaga M, Sotiropoulos G, Karmaniolas K,
Pelekanos N, Papadavid E and Lekka A: Serum resistin: A biomarker
of breast cancer in postmenopausal women? Association with
clinicopathological characteristics, tumor markers, inflammatory
and metabolic parameters. Clin Biochem. 46:584–590. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jardé T, Perrier S, Vasson MP and
Caldefie-Chézet F: Molecular mechanisms of leptin and adiponectin
in breast cancer. Eur J Cancer. 47:33–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tessitore L, Vizio B, Jenkins O, De
Stefano I, Ritossa C, Argiles JM, Benedetto C and Mussa A: Leptin
expression in colorectal and breast cancer patients. Int J Mol Med.
5:421–426. 2000.PubMed/NCBI
|
|
10
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual (7th). Springer.
New York, NY: 2010.
|
|
11
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
Insulin resistance and beta-cell function from fasting plasma
glucose and insulin concentrations in man. Diabetologia.
28:412–419. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim JG, Kim EO, Jeong BR, Min YJ, Park JW,
Kim ES, Namgoong IS, Kim YI and Lee BJ: Visfatin stimulates
proliferation of MCF-7 human breast cancer cells. Mol Cells.
30:341–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Filková M, Haluzík M, Gay S and Senolt L:
The role of resistin as a regulator of inflammation: Implications
for various human pathologies. Clin Immunol. 133:157–170. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo
RL, Wu D, Cooper GJ and Xu A: Adiponectin modulates the glycogen
synthase kinase-3beta/beta-catenin signaling pathway and attenuates
mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res.
66:11462–11470. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kosova F, Coskun T, Kaya Y, Kara E and Ari
Z: Adipocytokine levels of colon cancer patients before and after
treatment. Bratisl Lek Listy. 114:394–397. 2013.PubMed/NCBI
|
|
16
|
Thompson LH and Suit HD: Proliferation
kinetics of x-irradiated mouse L cells studied WITH TIME-lapse
photography. II. Int J Radiat Biol Relat Stud Phys Chem Med.
15:347–362. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dent P, Yacoub A, Contessa J, Caron R,
Amorino G, Valerie K, Hagan MP, Grant S and Schmidt-Ullrich R:
Stress and radiation-induced activation of multiple intracellular
signaling pathways. Radiat Res. 159:283–300. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Williams J, Ding I, Hernady E, Liu
W, Smudzin T, Finkelstein JN, Rubin P and Okunieff P: Radiation
pneumonitis and early circulatory cytokine markers. Semin Radiat
Oncol. 12(Suppl 1): 26–33. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rubin P, Johnston CJ, Williams JP,
McDonald S and Finkelstein JN: A perpetual cascade of cytokines
postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol
Biol Phys. 33:99–109. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fu XL, Huang H, Bentel G, Clough R, Jirtle
RL, Kong FM, Marks LB and Anscher MS: Predicting the risk of
symptomatic radiation-induced lung injury using both the physical
and biologic parameters V30 and transforming growth factor β. Int J
Radiat Oncol Biol Phys. 50:899–908. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Paris F, Fuks Z, Kang A, Capodieci P, Juan
G, Ehleiter D, Haimovitz-Friedman A, Cordon-Cardo C and Kolesnick
R: Endothelial apoptosis as the primary lesion initiating
intestinal radiation damage in mice. Science. 293:293–297. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hauer-Jensen M, Kong FM, Fink LM and
Anscher MS: Circulating thrombomodulin during radiation therapy of
lung cancer. Radiat Oncol Investig. 7:238–242. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kaaks R: Nutrition, hormones, and breast
cancer: Is insulin the missing link? Cancer Causes Control.
7:605–625. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vona-Davis L, Howard-McNatt M and Rose DP:
Adiposity, type 2 diabetes and the metabolic syndrome in breast
cancer. Obes Rev. 8:395–408. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chappell J, Leitner JW, Solomon S,
Golovchenko I, Goalstone ML and Draznin B: Effect of insulin on
cell cycle progression in MCF-7 breast cancer cells. Direct and
potentiating influence. J Biol Chem. 276:38023–38028.
2001.PubMed/NCBI
|
|
26
|
Ish-Shalom D, Christoffersen CT, Vorwerk
P, Sacerdoti-Sierra N, Shymko RM, Naor D and De Meyts P: Mitogenic
properties of insulin and insulin analogues mediated by the insulin
receptor. Diabetologia. 40(Suppl 2): S25–S31. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shafie SM and Hilf R: Insulin receptor
levels and magnitude of insulin-induced responses in
7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Cancer Res. 41:826–829. 1981.PubMed/NCBI
|
|
28
|
Shafie SM and Grantham FH: Role of
hormones in the growth and regression of human breast cancer cells
(MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst.
67:51–56. 1981.PubMed/NCBI
|
|
29
|
Mink PJ, Shahar E, Rosamond WD, Alberg AJ
and Folsom AR: Serum insulin and glucose levels and breast cancer
incidence: The atherosclerosis risk in communities study. Am J
Epidemiol. 56:349–352. 2002. View Article : Google Scholar
|
|
30
|
Eliassen AH, Tworoger SS, Mantzoros CS,
Pollak MN and Hankinson SE: Circulating insulin and c-peptide
levels and risk of breast cancer among predominately premenopausal
women. Cancer Epidemiol Biomarkers Prev. 16:161–164. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gunter MJ, Hoover DR, Yu H,
Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X,
Anderson GL, et al: Insulin, insulin-like growth factor-I, and risk
of breast cancer in postmenopausal women. J Natl Cancer Inst.
101:48–60. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kabat GC, Kim M, Caan BJ, Chlebowski RT,
Gunter MJ, Ho GY, Rodriguez BL, Shikany JM, Strickler HD, Vitolins
MZ, et al: Repeated measures of serum glucose and insulin in
relation to postmenopausal breast cancer. Int J Cancer.
125:2704–2710. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guinan E, Connolly EM, Healy LA, Carroll
PA, Kennedy MJ and Hussey J: The development of the metabolic
syndrome and insulin resistance after adjuvant treatment for breast
cancer. Cancer Nurs. 37:355–362. 2014.PubMed/NCBI
|
|
34
|
American Diabetes Association: Diagnosis
and classification of diabetes mellitus. Diabetes Care. 35(Suppl
1): S62–S69. 2010.
|
|
35
|
Demark-Wahnefried W, Peterson BL, Winer
EP, Marks L, Aziz N, Marcom PK, Blackwell K and Rimer BK: Changes
in weight, body composition, and factors influencing energy balance
among premenopausal breast cancer patients receiving adjuvant
chemotherapy. J Clin Oncol. 19:2381–2389. 2001.PubMed/NCBI
|
|
36
|
Carr MC: The emergence of the metabolic
syndrome with menopause. J Clin Endocrinol Metab. 88:2404–2411.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kaaja RJ: Metabolic syndrome and the
menopause. Menopause Int. 14:21–25. 2008.PubMed/NCBI
|
|
38
|
Steppan CM, Bailey ST, Bhat S, Brown EJ,
Banerjee RR, Wright CM, Patel HR, Ahima RS and Lazar MA: The
hormone resistin links obesity to diabetes. Nature. 409:307–312.
2001. View
Article : Google Scholar : PubMed/NCBI
|
